In conclusion, our results suggest that MYCT1 inhibits the expression of RUNX1 by inhibiting the binding ability between MAX and the RUNX1 promoter region, thereby affecting the proliferation and cell cycle process of DLBCL cells. This evidence concerns the gene MYCT1 and diffuse large B-cell lymphoma.